NT-219: First-In-Class, Novel Small Molecule Designed To Overcome Cancer Drug Resistance

NT-219: First-In-Class, Novel Small Molecule Designed To Overcome Cancer Drug Resistance

User Photo
Annual-Meeting

1 year
109 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Isaac Israel CEO @isaac2199 Of Kitov Pharmaceuticals Discusses NT-219: First-In-Class, Novel Small Molecule Designed To Overcome Cancer Drug Resistance.
Up Next Autoplay
User Photo